Chemoresistance and the Self-Maintaining Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 245 of the 245 references it cites were found in a registry or an index.
Abstract
The progression of cancer is associated with alterations in the tumor microenvironment, including changes in extracellular matrix (ECM) composition, matrix rigidity, hypervascularization, hypoxia, and paracrine factors. One key malignant phenotype of cancer cells is their ability to resist chemotherapeutics, and elements of the ECM can promote chemoresistance in cancer cells through a variety of signaling pathways, inducing changes in gene expression and protein activity that allow resistance. Furthermore, the ECM is maintained as an environment that facilitates chemoresistance, since its constitution modulates the phenotype of cancer-associated cells, which themselves affect the microenvironment. In this review, we discuss how the properties of the tumor microenvironment promote chemoresistance in cancer cells, and the interplay between these external stimuli. We focus on both the response of cancer cells to the external environment, as well as the maintenance of the external environment, and how a chemoresistant phenotype emerges from the complex signaling network present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Items 201–245 of 245
Growth factors in tumor microenvironment
Zhang, X., Nie, D., & Chakrabarty, S. (2009) · Frontiers in bioscience · doi:10.2741/3612 · Cited by 97 · cited 2×
“Activation of the PI3K/Akt oncogenic signaling pathway lies downstream of external growth factors, which are upregulated within the cancer microenvironment [4].”
BackgroundStretching Fibroblasts Remodels Fibronectin and Alters Cancer Cell Migration
Ao, M., Brewer, B. M., Yang, L., Franco Coronel, O. E., Hayward, S. W., Webb, D. J., & Li, D. (2015) · Scientific Reports · doi:10.1038/srep08334 · Cited by 96 · cited 1×
“Fibronectin alignment by fibroblasts is also upregulated by a stiff matrix [224].”
BackgroundYAP modulates TGF-β1-induced simultaneous apoptosis and EMT through upregulation of the EGF receptor
Liu, Y., He, K., Hu, Y., Guo, X., Wang, D., Shi, W., Li, J., & Song, J. (2017) · Scientific Reports · doi:10.1038/srep45523 · Cited by 92 · cited 1×
“Interestingly, YAP overexpression has been shown to shift the response of cells to TGF-β from apoptosis to cell survival, much like extracellular rigidity [150].”
BackgroundChemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer
Ricciardelli, C., Ween, M. P., Lokman, N. A., Tan, I. A., Pyragius, C. E., & Oehler, M. K. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-476 · Cited by 90 · cited 2×
“This study also showed that carboplatin chemotherapy upregulates hyaluronan expression, and therefore facilitates therapy-induced chemoresistance through MRP2 [107].”
BackgroundLI, J., LIU, H., YU, J., & YU, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3356 · Cited by 90 · cited 1×
“Doxorubicin is commonly used in colon cancer, but as the tumor progresses, it can switch from being cytotoxic to inducing EMT [22].”
BackgroundHIF-1α and GLUT1 Gene Expression is Associated with Chemoresistance of Acute Myeloid Leukemia
Song, K., Li, M., Xu, X., Xuan, L., Huang, G., Song, X., & Liu, Q. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.4.1823 · Cited by 89 · cited 1×
“The activity of the proteins GLUT1 and GLUT3, which transport glucose into the cell in a rate-limiting reaction in glycolysis, is also increased by hypoxia, and has been shown to desensitize acute myeloid leukemia cells to adriamycin [100].”
BackgroundCheng, Z.-X., Sun, B., Wang, S.-J., Gao, Y., Zhang, Y.-M., Zhou, H.-X., Jia, G., Wang, Y.-W., Kong, R., Pan, S.-H., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023752 · Cited by 88
The Hippo pathway in chemotherapeutic drug resistance
Zhao, Y., & Yang, X. (2015) · International Journal of Cancer · doi:10.1002/ijc.29293 · Cited by 86 · cited 1×
“Multiple members of the Hippo pathway, including mammalian ste20-like protein (MST), large tumor suppressor kinase 1/2 (LATS1/2), and YAP have been shown to have important roles, when either upregulated or downregulated, in promoting cell resistance to drugs, including cisplatin, doxorubicin, and paclitaxel [32].”
BackgroundB-cell activating factor in the pathophysiology of multiple myeloma: a target for therapy?
Hengeveld, P. J., & Kersten, M. J. (2015) · Blood Cancer Journal · doi:10.1038/bcj.2015.3 · Cited by 85 · cited 1×
“This receptor is activated by B-cell-activating factor (BAFF), a protein that is abundantly present in the bone marrow microenvironment that promotes multiple myeloma [182].”
BackgroundSubstrate stiffness regulates primary hepatocyte functions
Natarajan, V., Berglund, E. J., Chen, D. X., & Kidambi, S. (2015) · RSC Advances · doi:10.1039/c5ra15208a · Cited by 84 · cited 1×
“The activity of cytochrome P450 has been shown to be affected by substrate stiffness for hepatocytes, where a softer substrate (2 kPa) showed higher activity than a stiff tissue culture plate surface [138].”
BackgroundBreast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition
Curran, C. S., & Keely, P. J. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.11.016 · Cited by 84 · cited 1×
“The hypoxia-associated miR-210 is a driving factor for this transformation [215], in addition to TGF-β in the stroma, which is secreted by cancer cells following hypoxia [216].”
BackgroundRole of cancer-associated fibroblasts in invasion and metastasis of gastric cancer
Yu, Y. H., Wang, L., & Wang, R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i33.9717 · Cited by 82 · cited 1×
“Hypoxia seems to affect CAFs primarily through regulating their expression of paracrine factors, such as VEGF and angiopoetin, both of which promote angiogenesis [217].”
BackgroundBosnian, F. T., Havenith, M. G., & Cleutjens, J. P. M. (1985) · Ultrastructural Pathology · doi:10.3109/01913128509141519 · Cited by 82
Colom, A., Galgoczy, R., Almendros, I., Xaubet, A., Farré, R., & Alcaraz, J. (2013) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34946 · Cited by 81 · cited 1×
“Oxygen diffusion within collagen matrices has been shown to be reduced with an increased density of collagen, reconstituted basement membrane, and fibrin, as determined through in vitro studies [228].”
BackgroundYUAN, Y., LI, D., LI, H., WANG, L., TIAN, G., & DONG, Y. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4550 · Cited by 79 · cited 1×
“Overexpression of YAP in pancreatic cancer cells has been shown to promote resistance to gemcitabine through the activation of the Akt pathway [148].”
BackgroundMechanotransduction in talin through the interaction of the R8 domain with DLC1
Haining, A. W. M., Rahikainen, R., Cortes, E., Lachowski, D., Rice, A., von Essen, M., Hytönen, V. P., & del Río Hernández, A. (2018) · PLOS Biology · doi:10.1371/journal.pbio.2005599 · Cited by 77 · cited 1×
“The unfolding of talin in response to force, caused by the tension between intracellular contractility and external stiffness, leads to the exposure of cryptic intracellular binding sites that allow binding of effector proteins [53].”
BackgroundSelf-citationTriantafillu, U. L., Park, S., Klaassen, N. L., Raddatz, A. D., & Kim, Y. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.3865 · Cited by 77 · cited 1×
“Interestingly, shear stress has also been shown to promote a cancer stem cell-like phenotype in breast cancer cells without inducing EMT [194].”
BackgroundTan, Q., Saggar, J. K., Yu, M., Wang, M., & Tannock, I. F. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000131 · Cited by 73 · cited 2×
“The diffusion of drugs through the stroma depends on their concentration gradient, molecular weight, and half-life, whereas convection relies on a pressure gradient and the structure of the environment [9].”
BackgroundHypoxia‐Inducible Factor Prolyl‐Hydroxylase: Purification and Assays of PHD2
Hewitson, K. S., Schofield, C. J., & Ratcliffe, P. J. (2007) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(07)35002-7 · Cited by 71 · cited 1×
“This modification promotes HIF-α degradation [39].”
A paradigm for therapy-induced microenvironmental changes in solid tumors leading to drug resistance
Yu, J., Kerbel, R. S., & Coomber, B. L. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700913.x · Cited by 71 · cited 1×
“In another mechanism, those cancer cells within the heterogenous population which are less vessel dependent, are selected for by anti-angiogenic treatment, and therefore therapy-induced chemoresistance emerges [73].”
BackgroundCheng, Z., Wang, D., LIU, T., Liu, W., Xia, W.-B., XU, J., ZHANG, Y.-H., Qu, Y., Guo, L., Ding, L., et al. (2014) · Oncology Reports · doi:10.3892/or.2014.3022 · Cited by 70
Zhang, R., Ma, M., Lin, X.-H., Liu, H.-H., Chen, J., Chen, J., Gao, D.-M., Cui, J.-F., Ren, Z.-G., & Chen, R.-X. (2018) · BMC Cancer · doi:10.1186/s12885-018-4820-9 · Cited by 68 · cited 1×
“Collagen I has been shown to promote MAPK activation in hepatocellular carcinoma cells [124], and to promote chemoresistance in ovarian cancer cells through the activation of Akt and pyruvate dehydrogenase kinase 1 (PDK1) [125].”
BackgroundCortes, E., Lachowski, D., Rice, A., Chronopoulos, A., Robinson, B., Thorpe, S., Lee, D. A., Possamai, L. A., Wang, H., Pinato, D. J., et al. (2019) · Hepatology · doi:10.1002/hep.30193 · Cited by 64
Self-citationBillottet, C., Tuefferd, M., Gentien, D., Rapinat, A., Thiery, J., Broët, P., & Jouanneau, J. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21667 · Cited by 64 · cited 1×
“FGF induces EMT in bladder carcinoma cells [164], and EGF induces E-cadherin endocytosis and the expression of Snail and Twist [165].”
BackgroundZhu, G., Huang, C., Feng, Z.-Z., Lv, X.-H., & Qiu, Z. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2841-4 · Cited by 61
Karajannis, M. A., Vincent, L., DiRenzo, R., Shmelkov, S. V., Zhang, F., Feldman, E. J., Böhlen, P., Zhu, Z., Sun, H., Kussie, P. H., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404203 · Cited by 61
Dzobo, K., Senthebane, D. A., Rowe, A., Thomford, N. E., Mwapagha, L. M., Al-Awwad, N., Dandara, C., & Parker, M. I. (2016) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2016.0152 · Cited by 59
Dzobo, K., Senthebane, D. A., Thomford, N. E., Rowe, A., Dandara, C., & Parker, M. I. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0174 · Cited by 55 · cited 1×
“The varied population of cells present in the microenvironment, including CAFs and cancer-associated macrophages, are highly heterogenous [203].”
BackgroundHour, T., Chung, S., Kang, W.-Y., Lin, Y., Chuang, S.-J., Huang, A., Wu, W., Huang, S., Huang, C., & Pu, Y. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1275-x · Cited by 55 · cited 1×
“Furthermore, the activation of EGFR has been shown to activate the expression of P-glycoprotein through the Akt pathway in docetaxel-resistant prostate cancer cells in response to docetaxel [160].”
Backgrounddu Souich, P., & Fradette, C. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.586630 · Cited by 54 · cited 1×
“For example, acute hypoxia upregulates the cytochrome P450 isoform CYP3A6 downstream of MAPK activation [76], and this process may occur within tumors.”
BackgroundTopalovski, M., Hagopian, M., Wang, M., & Brekken, R. A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.730945 · Cited by 53
Kim, W., Seok Kang, Y., Soo Kim, J., Shin, N.-Y., Hanks, S. K., & Song, W. K. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-10-0991 · Cited by 51 · cited 1×
“For example, the engagement of fibronectin or laminin with integrins can attenuate TGF-β signaling, allowing cell cycle progression [122].”
BackgroundGPER in CAFs regulates hypoxia-driven breast cancer invasion in a CTGF-dependent manner
Ren, J., Guo, H., Wu, H., Tian, T., Dong, D., Zhang, Y., Sui, Y.-X., Zhang, Y., Zhao, D., Wang, S., et al. (2015) · Oncology Reports · doi:10.3892/or.2015.3779 · Cited by 50 · cited 1×
“IL-6 and connective tissue growth factor are also upregulated in CAFs in response to hypoxia, through the G protein-coupled estrogen receptor [218].”
BackgroundShah, A. D., Bouchard, M. J., & Shieh, A. C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142337 · Cited by 50 · cited 16×
“The aberrant and leaky vasculature is associated with an increase in interstitial fluid pressure (IFP).”
BackgroundInfluentialFluid shear stress induces epithelial-mesenchymal transition (EMT) in Hep-2 cells
Liu, S., Zhou, F., Shen, Y., Zhang, Y., Yin, H., Zeng, Y., Liu, J., Yan, Z., & Liu, X. (2016) · Oncotarget · doi:10.18632/oncotarget.8765 · Cited by 46
MECHANISMS OF ANTICANCER DRUGS RESISTANCE: AN OVERVIEW
Chorawala, M. R., Oza, P., & Shah, G. B. (2012) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2012.040101 · Cited by 45 · cited 1×
“DNA, cyclophosphamide alkylates DNA to alter its structure, and 5-fluorouracil prevents the synthesis of DNA nucleotides, all of which inhibit DNA replication, and therefore prevent cell growth and promote apoptosis [6].”
BackgroundSh, H., Wang, C., Zj, H., Liu, F., Cw, X., Xl, L., & Chen, G.-Q. (2016) · PubMed · Cited by 44
Okumura, Y., Noda, T., Eguchi, H., Sakamoto, T., Iwagami, Y., Yamada, D., Asaoka, T., Wada, H., Kawamoto, K., Gotoh, K., et al. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6670-8 · Cited by 42 · cited 1×
“For example, in biliary tract cancer, hypoxia has been show to promote the expression of procollagen-lysine 2-oxoglutarate 5-dioxygenase 2 (PLOD2), a collagen modifying enzyme, which can promote EMT and resistance to gemcitabine [88].”
BackgroundNurwidya, F., Takahashi, F., Minakata, K., Murakami, A., & Takahashi, K. (2012) · Anatomy & Cell Biology · doi:10.5115/acb.2012.45.2.73 · Cited by 38 · cited 1×
“This complex then activates downstream signaling [40,41].”
Zhang, B., Wang, H., Jiang, T., Jin, K., Luo, Z., Shi, W., Mei, H., Wang, H., Hu, Y., Pang, Z., et al. (2018) · Journal of drug targeting · doi:10.1080/1061186x.2018.1452243 · Cited by 29 · cited 1×
“The disruption of solid stress within the microenvironment by various inhibitors has been shown to improve vascular perfusion and therefore drug delivery [142,143].”
BackgroundPeh, J., Boudreau, M. W., Smith, H. M., & Hergenrother, P. J. (2018) · Cell chemical biology · doi:10.1016/j.chembiol.2018.05.008 · Cited by 29 · cited 1×
“The MAPK pathway component MEK1/2 is inhibited by the targeted therapeutics trametinib and cobimetinib, but the development of secondary mutations can lead to the circumvention of this therapy [28].”
BackgroundGraff, B. A., Vangberg, L., & Rofstad, E. K. (2004) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20028 · Cited by 24 · cited 1×
“Further studies have shown that nanoparticles cannot efficiently penetrate into tumors, and they instead become localized in peripheral regions [105,106].”
BackgroundDrubay, V., Skrypek, N., Cordiez, L., Vasseur, R., Schulz, C., Boukrout, N., Duchêne, B., Coppin, L., SEUNINGEN, I. V., & Jonckheere, N. (2018) · Cancers · doi:10.3390/cancers10080254 · Cited by 23
Tchafa, A. M., Ta, M., Reginato, M. J., & Shieh, A. C. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0471 · Cited by 21 · cited 1×
“IFP has also been shown to promote the EMT-dependent invasion of ErbB2-positive breast cancer cells [191].”
BackgroundZHU, S.-K., Zhou, Y., Cheng, C., Zhong, S., Wu, H.-Q., Wang, B., Fan, P., Xiong, J., Yang, H.-J., & Wu, H. (2014) · Molecular and Clinical Oncology · doi:10.3892/mco.2014.357 · Cited by 11 · cited 1×
“In addition to collagen and fibronectin modulation, hypoxia can promote ECM degradation and remodeling by upregulating the expression of MMPs, with MMP-2 upregulation observed in pancreatic cancer [208], and MMP-9 expression observed in breast cancer [209] in response to low oxygen.”
Background
Cited by
Emran, T. B., Shahriar, A., Mahmud, A. R., Rahman, T., Abir, M. H., Siddiquee, M. F. R., Ahmed, H., Rahman, N., Nainu, F., Wahyudin, E., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.891652 · Cited by 606
“MDRmay develop due to oncogene mutations, changes in the tumor microenvironment (TME), tumor heterogeneity, target site mutations, or epigenetic changes (33, 34) (Figure 1).”
BackgroundA Forward Vision for Chemodynamic Therapy: Issues and Opportunities
Zhao, P., Li, H., & Bu, W. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202210415 · Cited by 308
Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer
Zhai, J., Shen, J., Xie, G., Wu, J., He, M., Gao, L., Zhang, Y., Yao, X., & Shen, L. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.002 · Cited by 272
Guerini, A. E., Triggiani, L., Maddalo, M., Bonù, M. L., Frassine, F., Baiguini, A., Alghisi, A., Tomasini, D., Borghetti, P., Pasinetti, N., et al. (2019) · Cancers · doi:10.3390/cancers11091284 · Cited by 146
Role of Wnt/β‐Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer
Yuan, S., Tao, F., Zhang, X., Zhang, Y., Sun, X., & Wu, D. (2020) · BioMed Research International · doi:10.1155/2020/9390878 · Cited by 131
“As the main component of the stroma, cancer-associated fibroblasts (CAFs), different from normal fibroblasts in the TME, exert inherent support on cancer cells via secretion of molecular messengers and cell-to-cell contact [74].”
Background
Metadata
- Authors
- Yeldag, G., Rice, A., & Del Río Hernández, A.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2018-11-28
- Volume
- 10
- Issue
- 12
- Pages
- 471
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W2902854367
- Cited by
- 214
- References
- 245
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.